{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:52:15Z","timestamp":1791924735066,"version":"4.3.4"},"reference-count":79,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK39773"],"award-info":[{"award-number":["R01DK39773"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK072381"],"award-info":[{"award-number":["R01DK072381"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seminarsinnephrology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.semnephrol.2026.151724","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T19:58:38Z","timestamp":1789415918000},"page":"151724","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Kidney Injury Molecule-1: A Biomarker, Signalling Mediator, and Therapeutic Target"],"prefix":"10.1016","volume":"46","author":[{"given":"Ahmed","family":"Soliman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaharu","family":"Ichimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph V.","family":"Bonventre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.semnephrol.2026.151724_bib0001","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1074\/jbc.273.7.4135","article-title":"Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury","volume":"273","author":"Ichimura","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semnephrol.2026.151724_bib0002","first-page":"293","article-title":"Kidney injury molecule-1: a translational journey","volume":"125","author":"Bonventre","year":"2014","journal-title":"Trans Am Clin Climatol Assoc"},{"issue":"11","key":"10.1016\/j.semnephrol.2026.151724_bib0003","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1093\/ndt\/gfp010","article-title":"Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more","volume":"24","author":"Bonventre","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151724_bib0004","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/ki.2009.96","article-title":"A rapid urine test for early detection of kidney injury","volume":"76","author":"Vaidya","year":"2009","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.semnephrol.2026.151724_bib0005","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nbt.1623","article-title":"Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies","volume":"28","author":"Vaidya","year":"2010","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151724_bib0006","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1523-1755.2002.00433.x","article-title":"Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury","volume":"62","author":"Han","year":"2002","journal-title":"Kidney Int"},{"issue":"42","key":"10.1016\/j.semnephrol.2026.151724_bib0007","doi-asserted-by":"crossref","first-page":"39739","DOI":"10.1074\/jbc.M200562200","article-title":"Shedding of kidney injury molecule-1, a putative adhesion protein involved in renal regeneration","volume":"277","author":"Bailly","year":"2002","journal-title":"J Biol Chem"},{"issue":"1-3","key":"10.1016\/j.semnephrol.2026.151724_bib0008","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.tox.2010.04.015","article-title":"Evaluation of the usefulness of urinary biomarkers for nephrotoxicity in rats","volume":"273","author":"Tonomura","year":"2010","journal-title":"Toxicology"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151724_bib0009","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/toxsci\/kfs268","article-title":"Novel assays for detection of urinary KIM-1 in mouse models of kidney injury","volume":"131","author":"Sabbisetti","year":"2013","journal-title":"Toxicol Sci"},{"issue":"2","key":"10.1016\/j.semnephrol.2026.151724_bib0010","doi-asserted-by":"crossref","first-page":"F517","DOI":"10.1152\/ajprenal.00291.2005","article-title":"Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury","volume":"290","author":"Vaidya","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"issue":"8","key":"10.1016\/j.semnephrol.2026.151724_bib0011","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/sj.ki.5002467","article-title":"Kidney injury molecule-1 is an early biomarker of cadmium nephrotoxicity","volume":"72","author":"Prozialeck","year":"2007","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151724_bib0012","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1681\/ASN.2010111124","article-title":"Imperfect gold standards for kidney injury biomarker evaluation","volume":"23","author":"Waikar","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151724_bib0013","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/toxsci\/kfm260","article-title":"Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium","volume":"101","author":"Zhou","year":"2008","journal-title":"Toxicol Sci"},{"issue":"3","key":"10.1016\/j.semnephrol.2026.151724_bib0014","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.taap.2009.01.016","article-title":"Expression of kidney injury molecule-1 (Kim-1) in relation to necrosis and apoptosis during the early stages of Cd-induced proximal tubule injury","volume":"238","author":"Prozialeck","year":"2009","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.semnephrol.2026.151724_bib0015","unstructured":"European Medicines Agency, Committee for Medicinal Products for Human Use. Final Conclusions on the Pilot Joint EMEA\/FDA VXDS Experience on Qualification of Nephrotoxicity Biomarkers, 2009, European Medicines Agency, 2009.EMEA\/679719\/2008 Rev. 1. Accessed September 2, 2026. https:\/\/www.ema.europa.eu\/en\/documents\/regulatory-procedural-guideline\/final-conclusions-pilot-joint-european-medicines-agency-food-and-drug-administration-vxds-experience-qualification-nephrotoxicity-biomarkers_en.pdf"},{"key":"10.1016\/j.semnephrol.2026.151724_bib0016","unstructured":"MJ. Blank, De Felice A, Goodsaid F, et al.Review of qualification data for biomarkers of nephrotoxicity Submitted by the Predictive Safety Testing Consortium.Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 2009. Accessed September 2, 2026. https:\/\/www.fda.gov\/media\/87781\/download"},{"issue":"5","key":"10.1016\/j.semnephrol.2026.151724_bib0017","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/sj.ki.5002697","article-title":"Kidney injury molecule-1 expression in transplant biopsies is a sensitive measure of cell injury","volume":"73","author":"Zhang","year":"2008","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.semnephrol.2026.151724_bib0018","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.2215\/CJN.01910310","article-title":"Urinary expression of kidney injury markers in renal transplant recipients","volume":"5","author":"Szeto","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.semnephrol.2026.151724_bib0019","doi-asserted-by":"crossref","first-page":"F1637","DOI":"10.1152\/ajprenal.00060.2018","article-title":"Kidney injury molecule-1 identifies antemortem injury in postmortem adult and fetal kidney","volume":"315","author":"Yin","year":"2018","journal-title":"Am J Physiol Renal Physiol"},{"issue":"9","key":"10.1016\/j.semnephrol.2026.151724_bib0020","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1172\/JCI45361","article-title":"Chronic epithelial kidney injury molecule-1 expression causes murine kidney fibrosis","volume":"123","author":"Humphreys","year":"2013","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.semnephrol.2026.151724_bib0021","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1053\/j.ajkd.2021.05.013","article-title":"Plasma kidney injury molecule 1 in CKD: findings from the Boston Kidney Biopsy Cohort and CRIC studies","volume":"79","author":"Schmidt","year":"2022","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.semnephrol.2026.151724_bib0022","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.semnephrol.2021.09.003","article-title":"Plasma and urine biomarkers of CKD: a review of findings in the CKiD study","volume":"41","author":"Sandokji","year":"2021","journal-title":"Semin Nephrol"},{"issue":"10","key":"10.1016\/j.semnephrol.2026.151724_bib0023","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1681\/ASN.2013070758","article-title":"Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes","volume":"25","author":"Sabbisetti","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.semnephrol.2026.151724_bib0024","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nrneph.2015.3","article-title":"Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD","volume":"11","author":"Ferenbach","year":"2015","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151724_bib0025","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/s41467-024-45706-0","article-title":"Predicting proximal tubule failed repair drivers through regularized regression analysis of single cell multiomic sequencing","volume":"15","author":"Ledru","year":"2024","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.semnephrol.2026.151724_bib0026","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.cmet.2021.04.004","article-title":"KIM-1 mediates fatty acid uptake by renal tubular cells to promote progressive diabetic kidney disease","volume":"33","author":"Mori","year":"2021","journal-title":"Cell Metab"},{"issue":"6","key":"10.1016\/j.semnephrol.2026.151724_bib0027","doi-asserted-by":"crossref","first-page":"F1472","DOI":"10.1152\/ajprenal.00619.2009","article-title":"Transcriptional analysis of kidneys during repair from AKI reveals possible roles for NGAL and KIM-1 as biomarkers of AKI-to-CKD transition","volume":"298","author":"Ko","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"issue":"5","key":"10.1016\/j.semnephrol.2026.151724_bib0028","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.kint.2017.11.024","article-title":"Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development","volume":"93","author":"Nowak","year":"2018","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.semnephrol.2026.151724_bib0029","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/ki.2015.314","article-title":"Increased plasma kidney injury molecule-1 suggests early progressive renal decline in non-proteinuric patients with type 1 diabetes","volume":"89","author":"Nowak","year":"2016","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.semnephrol.2026.151724_bib0030","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1053\/j.ajkd.2021.09.018","article-title":"Associations of plasma biomarkers of inflammation, fibrosis, and kidney tubular injury with progression of diabetic kidney disease: a cohort study","volume":"79","author":"Gutierrez","year":"2022","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151724_bib0031","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1681\/ASN.2020040487","article-title":"Association of multiple plasma biomarker concentrations with progression of prevalent diabetic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) study","volume":"32","author":"Schrauben","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.semnephrol.2026.151724_bib0032","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1681\/ASN.2019070723","article-title":"Plasma biomarkers of tubular injury and inflammation are associated with CKD progression in children","volume":"31","author":"Greenberg","year":"2020","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.semnephrol.2026.151724_bib0033","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/ejhf.426","article-title":"Plasma kidney injury molecule-1 in heart failure: renal mechanisms and clinical outcome","volume":"18","author":"Emmens","year":"2016","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"10.1016\/j.semnephrol.2026.151724_bib0034","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.34067\/KID.0000000000000183","article-title":"Associations of biomarkers of kidney tubule health, injury, and inflammation with left ventricular hypertrophy in children with CKD","volume":"4","author":"Jiang","year":"2023","journal-title":"Kidney360"},{"issue":"7","key":"10.1016\/j.semnephrol.2026.151724_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2025.101024","article-title":"Association of plasma KIM-1, TNFR-1, and TNFR-2 with cardiovascular outcomes and all-cause mortality in individuals with chronic kidney disease: an ancillary analysis of SPRINT","volume":"7","author":"Wettersten","year":"2025","journal-title":"Kidney Med"},{"issue":"3","key":"10.1016\/j.semnephrol.2026.151724_bib0036","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/MNH.0000000000000605","article-title":"Acute kidney injury and maladaptive tubular repair leading to renal fibrosis","volume":"29","author":"Yu","year":"2020","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"6","key":"10.1016\/j.semnephrol.2026.151724_bib0037","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/cpt.3237","article-title":"Dapagliflozin reduces urinary kidney injury biomarkers in chronic kidney disease irrespective of albuminuria level","volume":"115","author":"Cho","year":"2024","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.semnephrol.2026.151724_bib0038","doi-asserted-by":"crossref","unstructured":"de la Rambelje MA, Jongs N, Greasley PJ, et al. New insights from DAPA-CKD indicate dapagliflozin modulates key pathways related to kidney outcomes. Preprint. Posted online July 27, 2026. Kidney Int. doi:10.1016\/j.kint.2026.06.043","DOI":"10.1016\/j.kint.2026.06.043"},{"issue":"5","key":"10.1016\/j.semnephrol.2026.151724_bib0039","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1172\/JCI34487","article-title":"Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells","volume":"118","author":"Ichimura","year":"2008","journal-title":"J Clin Invest"},{"issue":"19","key":"10.1016\/j.semnephrol.2026.151724_bib0040","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.15252\/embj.201489838","article-title":"KIM-1-\/TIM-1-mediated phagocytosis links ATG5-\/ULK1-dependent clearance of apoptotic cells to antigen presentation","volume":"34","author":"Brooks","year":"2015","journal-title":"EMBO J"},{"issue":"10","key":"10.1016\/j.semnephrol.2026.151724_bib0041","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.3390\/v14102124","article-title":"Single nucleotide variants of the human TIM-1 IgV domain with reduced ability to promote viral entry into cells","volume":"14","author":"Hattori","year":"2022","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.semnephrol.2026.151724_bib0042","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.immuni.2007.11.011","article-title":"TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells","volume":"27","author":"Kobayashi","year":"2007","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.semnephrol.2026.151724_bib0043","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1172\/JCI75417","article-title":"KIM-1-mediated phagocytosis reduces acute injury to the kidney","volume":"125","author":"Yang","year":"2015","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.semnephrol.2026.151724_bib0044","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1681\/ASN.2007030325","article-title":"Shedding of the urinary biomarker kidney injury molecule-1 (KIM-1) is regulated by MAP kinases and juxtamembrane region","volume":"18","author":"Zhang","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.semnephrol.2026.151724_bib0045","doi-asserted-by":"crossref","first-page":"F205","DOI":"10.1152\/ajprenal.00638.2013","article-title":"Accelerated receptor shedding inhibits kidney injury molecule-1 (KIM-1)-mediated efferocytosis","volume":"307","author":"Gandhi","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"issue":"5","key":"10.1016\/j.semnephrol.2026.151724_bib0046","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/jb\/mvs082","article-title":"Shedding of kidney injury molecule-1 by membrane-type 1 matrix metalloproteinase","volume":"152","author":"Guo","year":"2012","journal-title":"J Biochem"},{"issue":"5","key":"10.1016\/j.semnephrol.2026.151724_bib0047","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.ajpath.2015.02.003","article-title":"Kidney injury molecule-1 protects against Galpha12 activation and tissue damage in renal ischemia-reperfusion injury","volume":"185","author":"Ismail","year":"2015","journal-title":"Am J Pathol"},{"issue":"7","key":"10.1016\/j.semnephrol.2026.151724_bib0048","doi-asserted-by":"crossref","first-page":"F607","DOI":"10.1152\/ajprenal.00169.2015","article-title":"G protein alpha(12) (Galpha(12)) is a negative regulator of kidney injury molecule-1-mediated efferocytosis","volume":"310","author":"Ismail","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"10.1016\/j.semnephrol.2026.151724_bib0049","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0092-8674(00)80675-3","article-title":"Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans","volume":"100","author":"Brown","year":"2000","journal-title":"Cell"},{"issue":"15","key":"10.1016\/j.semnephrol.2026.151724_bib0050","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201899456","article-title":"Proteolytic ectodomain shedding of membrane proteins in mammals\u2014hardware, concepts, and recent developments","volume":"37","author":"Lichtenthaler","year":"2018","journal-title":"EMBO J"},{"issue":"10","key":"10.1016\/j.semnephrol.2026.151724_bib0051","doi-asserted-by":"crossref","first-page":"6877","DOI":"10.1002\/jcp.26578","article-title":"Tctex-1, a novel interaction partner of kidney injury molecule-1, is required for efferocytosis","volume":"233","author":"Ismail","year":"2018","journal-title":"J Cell Physiol"},{"issue":"4","key":"10.1016\/j.semnephrol.2026.151724_bib0052","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/jcp.25181","article-title":"Kidney injury molecule-1 enhances endocytosis of albumin in renal proximal tubular cells","volume":"231","author":"Zhao","year":"2016","journal-title":"J Cell Physiol"},{"issue":"11","key":"10.1016\/j.semnephrol.2026.151724_bib0053","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/s41419-021-04271-w","article-title":"Relationship between lysosomal dyshomeostasis and progression of diabetic kidney disease","volume":"12","author":"Wu","year":"2021","journal-title":"Cell Death Dis"},{"issue":"12","key":"10.1016\/j.semnephrol.2026.151724_bib0054","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1007\/s00467-013-2652-z","article-title":"Lysosome dysfunction in the pathogenesis of kidney diseases","volume":"29","author":"Surendran","year":"2014","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"10.1016\/j.semnephrol.2026.151724_bib0055","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.kint.2022.05.006","article-title":"Defective KIM-1 phagocytosis does not predispose to acute graft dysfunction after kidney transplantation in humans","volume":"102","author":"Suri","year":"2022","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151724_bib0056","doi-asserted-by":"crossref","first-page":"6169","DOI":"10.1038\/s41467-023-41756-y","article-title":"Glycoproteomic landscape and structural dynamics of TIM family immune checkpoints enabled by mucinase SmE","volume":"14","author":"Chongsaritsinsuk","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.semnephrol.2026.151724_bib0057","first-page":"472A","volume":"13","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.semnephrol.2026.151724_bib0058","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1681\/ASN.2004070530","article-title":"Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma","volume":"16","author":"Han","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.semnephrol.2026.151724_bib0059","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/01.pas.0000213353.95508.67","article-title":"Human kidney injury molecule-1 (hKIM-1): a useful immunohistochemical marker for diagnosing renal cell carcinoma and ovarian clear cell carcinoma","volume":"31","author":"Lin","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.semnephrol.2026.151724_bib0060","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11255-013-0522-z","article-title":"Urine kidney injury molecule-1: a potential non-invasive biomarker for patients with renal cell carcinoma","volume":"46","author":"Zhang","year":"2014","journal-title":"Int Urol Nephrol"},{"issue":"2","key":"10.1016\/j.semnephrol.2026.151724_bib0061","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.eururo.2026.03.005","article-title":"KIM-1 in advanced papillary and clear cell renal cell carcinoma","volume":"90","author":"Coca Membribes","year":"2026","journal-title":"Eur Urol"},{"issue":"22","key":"10.1016\/j.semnephrol.2026.151724_bib0062","doi-asserted-by":"crossref","first-page":"5594","DOI":"10.1158\/1078-0432.CCR-18-1496","article-title":"KIM-1 as a blood-based marker for early detection of kidney cancer: a prospective nested case-control study","volume":"24","author":"Scelo","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.semnephrol.2026.151724_bib0063","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1158\/1078-0432.CCR-21-0025","article-title":"Plasma KIM-1 is associated with recurrence risk after nephrectomy for localized renal cell carcinoma: a trial of the ECOG-ACRIN Research Group (E2805)","volume":"27","author":"Xu","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.semnephrol.2026.151724_bib0064","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.annonc.2025.08.007","article-title":"Circulating kidney injury molecule-1 (KIM-1) and association with outcome to adjuvant immunotherapy in renal cell carcinoma","volume":"36","author":"Rini","year":"2025","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.semnephrol.2026.151724_bib0065","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1158\/0008-5472.CAN-13-1671","article-title":"HAVCR\/KIM-1 activates the IL-6\/STAT-3 pathway in clear cell renal cell carcinoma and determines tumor progression and patient outcome","volume":"74","author":"Cuadros","year":"2014","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151724_bib0066","article-title":"Kidney injury molecule-1 inhibits metastasis of renal cell carcinoma","volume":"11","author":"Lee","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151724_bib0067","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/0115665232402424250721114133","article-title":"Association of KIM-1 (HAVCR1) expression with the tumor immune microenvironment in clear cell renal cell carcinoma","volume":"26","author":"Vlachostergios","year":"2026","journal-title":"Curr Gene Ther"},{"issue":"22","key":"10.1016\/j.semnephrol.2026.151724_bib0068","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1200\/JCO.23.00699","article-title":"Plasma kidney injury molecule-1 for preoperative prediction of renal cell carcinoma versus benign renal masses, and association with clinical outcomes","volume":"42","author":"Xu","year":"2024","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.semnephrol.2026.151724_bib0069","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.7150\/jca.37285","article-title":"The immune infiltration in clear cell renal cell carcinoma and their clinical implications: a study based on TCGA and GEO databases","volume":"11","author":"Pan","year":"2020","journal-title":"J Cancer"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151724_bib0070","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s42003-020-01625-6","article-title":"Mapping the immune environment in clear cell renal carcinoma by single-cell genomics","volume":"4","author":"Borcherding","year":"2021","journal-title":"Commun Biol"},{"key":"10.1016\/j.semnephrol.2026.151724_bib0071","article-title":"Immune infiltration landscape in clear cell renal cell carcinoma implications","volume":"10","author":"Wang","year":"2020","journal-title":"Front Oncol"},{"issue":"6","key":"10.1016\/j.semnephrol.2026.151724_bib0072","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1111\/cas.14887","article-title":"Landscape of immune cell infiltration in clear cell renal cell carcinoma to aid immunotherapy","volume":"112","author":"Bai","year":"2021","journal-title":"Cancer Sci"},{"issue":"10","key":"10.1016\/j.semnephrol.2026.151724_bib0073","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1681\/ASN.2020111561","article-title":"Kim-1 targeted extracellular vesicles: a new therapeutic platform for RNAi to treat AKI","volume":"32","author":"Tang","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151724_bib0074","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1038\/s41467-023-40036-z","article-title":"A renal YY1-KIM1-DR5 axis regulates the progression of acute kidney injury","volume":"14","author":"Yang","year":"2023","journal-title":"Nat Commun"},{"issue":"18","key":"10.1016\/j.semnephrol.2026.151724_bib0075","doi-asserted-by":"crossref","first-page":"eadt3943","DOI":"10.1126\/sciadv.adt3943","article-title":"A rationally designed injury kidney targeting peptide library and its application in rescuing acute kidney injury","volume":"11","author":"Xiao","year":"2025","journal-title":"Sci Adv"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151724_bib0076","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41392-020-00304-6","article-title":"Augmented efficacy of exogenous extracellular vesicles targeted to injured kidneys","volume":"5","author":"Chen","year":"2020","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"10.1016\/j.semnephrol.2026.151724_bib0077","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1007\/s10637-020-00945-y","article-title":"Safety and efficacy of CDX-014, an antibody-drug conjugate directed against T cell immunoglobulin mucin-1 in advanced renal cell carcinoma","volume":"38","author":"McGregor","year":"2020","journal-title":"Invest New Drugs"},{"issue":"Pt 2","key":"10.1016\/j.semnephrol.2026.151724_bib0078","article-title":"Targeted degradation of kidney injury molecule 1 ameliorates acute kidney injury","volume":"340","author":"Xiao","year":"2026","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151724_bib0079","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/s41467-025-56223-z","article-title":"High-density lipoprotein nanoparticles spontaneously target to damaged renal tubules and alleviate renal fibrosis by remodeling the fibrotic niches","volume":"16","author":"He","year":"2025","journal-title":"Nat Commun"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929526000434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929526000434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:44:05Z","timestamp":1791924245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929526000434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":79,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0270929526000434"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2026.151724","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kidney Injury Molecule-1: A Biomarker, Signalling Mediator, and Therapeutic Target","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2026.151724","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"151724"}}